Senior Scientist Downstream Processing
Incyte
Senior Scientist Downstream Processing
Incyte
Biopharmaceutical company pursuing drug discovery.
Job SummaryThe Senior Scientist / Engineer, Downstream Manufacturing Technology, is responsible for leading downstream process technology transfers and supporting the successful introduction of new products at the Yverdon Bioplant. The role acts as a downstream process subject matter expert for GMP manufacturing, including facility fit assessments, plant modeling, process description definition, MES alignment, manufacturing support, troubleshooting, deviation investigation, process validation, and continued process verification. The position requires strong cross-functional collaboration with Production, Global Process Science, QA, QC, Engineering, and other key stakeholders to ensure robust, compliant, and scientifically sound downstream process implementation. Technology Transfer and New Product Introduction
Manufacturing Support and Troubleshooting
Documentation, Compliance, and Risk Management
Continuous Improvement and Collaboration
QualificationsEducation and Experience
Technical Expertise
GMP, Documentation, and Regulatory Knowledge
Leadership and Collaboration
|
Incyte develops and sells medicines by discovering and developing new drugs, focusing on diseases in inflammation, autoimmunity, and blood cancers. Its core product, Jakafi (ruxolitinib), is a JAK1/2 inhibitor approved to treat a rare blood cancer and works by blocking JAK enzymes to reduce abnormal blood cell growth. The company also expands its pipeline through research collaborations, partnerships, and acquisitions, such as the 2024 purchase of Escient Pharmaceuticals to strengthen its inflammation and autoimmune portfolio. Unlike some competitors that rely mainly on internal programs, Incyte combines in-house discovery with external collaborations and strategic deals to grow its drug candidates from early research to approved therapies. The goal is to deliver medicines that help patients with serious diseases by building a diverse, clinically validated portfolio of treatments through internal efforts and partnerships.
Explore more opportunities at Incyte